Teleflex Incorporated: Four-Year BIOMAG-I Study Results Presented at EuroPCR Confirm Long-Term Safety and Sustained Performance of the Freesolve Resorbable Magnesium Scaffold (DREAMS 3G)

Persistently Low Target Lesion Failure and No New Cardiac-Related Event Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the four-year follow-u...